期刊文献+

危重患者液体治疗 被引量:2

下载PDF
导出
摘要 液体治疗是重症患者常用的治疗手段,其治疗方案的合理与否对患者预后起着决定性作用。本文对液体治疗的途径、液体种类的优缺点以及液体治疗的并发症及监测进行了论述。
作者 朱研 陈宏首
出处 《临床药物治疗杂志》 2010年第5期26-28,共3页 Clinical Medication Journal
  • 相关文献

参考文献9

  • 1Vincent JL,Weil MH.Fluid challenge revisited[J].Critical Care Medicine,2006,34:1333-1337.
  • 2Hinder F,Stubbe HD,Van Aken H,et al.Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor -masked hypovolemia[J].Critical Care Medicine,2003,31:903-909.
  • 3安友仲.液体治疗的合理选择[J].中国实用外科杂志,2007,27(11):928-930. 被引量:5
  • 4Bahrami S,Zimmermann K,Szelenyi Z,et al.Small-volume fIuid resuscitation with hypertonic saline prevents inflammation but not mortality a rat model of hemorrhagic shock[J].Shock,2006,25:283-289.
  • 5Hashiguchi N,Lum L,Romeril E,et al.Hypertonic saline resuscitation:efficacy may require early treatment in severely injured patients[J].J Trauma,2007,62:299-306.
  • 6Christian Ertmer,Sebastian Rehberg,Hugo Van Aken,et al.Relevance of non-albumin colloids in intensive care medicine[J].Best Practice & Research Clinical Anaesthesiology,2009,23:193-212.
  • 7Haisch G,Boldt J,Krebs C,et al.The influence of intravascular volume therapy with a new hydroxyethyl starch preperation(6 % HES 130/0.4) on coagulation in patients undergoing major aldominal surgery[J].Anesth Analg,2001,92:565-571.
  • 8Jungheinrich C,Scharpf R,WargenauM,et al.The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%,500 mL) in mild to severe renal impairment[J].Anesth Analg,2002,95:544-551.
  • 9杜斌.感染性休克复苏治疗时的液体选择[J].中华医学杂志,2003,83(15):1374-1376. 被引量:9

共引文献12

同被引文献9

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部